Post hoc analysis of 3404 patients having PCI in the FAVOR III China trial: a rise in angiographic microcirculatory resistance of ≥85% vs <85% did not predict 3-year MACE (14.8% vs 12.4%; HR 1.18, 95% CI 0.95-1.45), except in those with post-PCI AMR ≥250.
Secondary analysisn = 3,404
Zhang et al. Prognostic Value of Angiographic Microcirculatory Resistance After Coronary Intervention: Insights From the FAVOR III China Trial